Dr. Regan Stinnett

President & CEO, Quantum Manufacturing Technologies, Inc.

United States

Elements Needed for Successful Commercialization of National Laboratory Technologies – A Case Study


In most countries commercialization of technologies originating in national laboratories involves several characteristic differences from similar commercialization activities undertaken by industry. These typically include differences in technology maturity, level of customer focus, level of expertise and resources required, and the definition of success.

In this talk we will highlight some special challenges that high tech start-up companies may face in commercializing national laboratory technologies and will suggest approaches to mitigate these challenges. Although commercialization of technologies from national laboratories can be difficult, it is possible to improve the prospects for their successful commercialization by careful selection, focus and partnering.


Regan Stinnett (Ph.D. Physics, University of Texas) worked at Sandia National Laboratories for 36 years in the areas of fusion, ion beams, microsystems, nanotechnology and materials technologies. During this period Regan left Sandia for 5 years to commercialize a new ion beam surface treatment technology. To do this he co-founded Quantum Manufacturing Technologies, Inc. where he served as President and CEO.

When Regan returned to Sandia his work emphasized the creation of partnerships between national laboratories, universities and industry. Regan has received the U.S. Department of Energy Award of Excellence for Contributions to the Nuclear Weapons Program and is the holder of 5 patents.

Regan served from 2010-2017 on the Executive Board of MANCEF as Vice President for the Americas.